Quanyou Wu

Quanyou Wu

Auto-generated profile, based on publicly available information

Quanyou Wu

Division of Abdominal Cancer Department of Medical Oncology Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology West China Hospital Sichuan University Chengdu China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2021 in Oncogene
Verified
Journal Article
Closed access
PDF file
QWQuanyou Wu
Quanyou Wu
YZYuan Zhang
Yuan Zhang
HAHaiyin An
Haiyin An
WSWei Sun
Wei Sun
RWRuozheng Wang
Ruozheng Wang
KZKaitai Zhang
Kaitai Zhang

5 July 2021 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
BZBotao Zhang
Botao Zhang
QWQuanyou Wu
Quanyou Wu
SCShujun Cheng
Shujun Cheng
WLWenbin Li
Wenbin Li
Despite many changes in alternative splicing events (ASEs) are frequently involved in various cancers, prognosis-related ASEs and drug treatment targets in glioblastoma multiforme (GBM) have not been well explored. ASEs participate in many biological behaviors in the initiation and progression of tumors, the aberrant ASE has been considered another hallmark of cancer, and the systematic study of alternative splicing may provide potential biomarkers for malignancies. In this study, we carried out a systematic analysis to characterize the ASE signatures in GBM cohort. Through comparing GBM tissues and nontumor tissues, a total of 48,191 differently expressed ASEs from 10,727 genes were obtained, and these aberrant ASEs play an important role in the oncogenic process. Then, we identified 514 ASEs independently associated with patient survival in GBM by univariate and multivariate Cox regression, including exon skip in CD3D, alternate acceptor site in POLD2, and exon skip in DCN. Those prognostic models built on ASEs of each splice type can accurately predict the outcome of GBM patients, and values for the area under curve were 0.97 in the predictive model based on alternate acceptor site. In addition, the splicing-regulatory network revealed an interesting correlation between survival-associated splicing factors and prognostic ASE corresponding genes. Moreover, these three hub splicing factors in splicing regulation network are the potential targets of some drugs. In conclusion, a systematic analysis of ASE signatures in GBM could serve as an indicator for identifying novel prognostic biomarkers and guiding clinical treatment.

14 August 2024 in Cancer
Verified
Journal Article
Closed access
PDF file
QWQuanyou Wu
Quanyou Wu
CHChunfang Hu
Chunfang Hu
LFLin Feng
Lin Feng
XYXin Yang
Xin Yang
YCYing Cui
Ying Cui
HGHuiqin Guo
Huiqin Guo

7 December 2021 in Research Square
Verified
Preprint
Open access
PDF file
WZWen Zhang
Wen Zhang
QWQuanyou Wu
Quanyou Wu
GLGuoliang Li
Guoliang Li
ZYZhenrong Yang
Zhenrong Yang
DKDefeng Kong
Defeng Kong
KZKaitai Zhang
Kaitai Zhang
Circulating tumor cell (CTC) clusters possess a much higher capability to seed metastasis than single CTCs. However, the mechanism underlying this phenomenon is still elusive and no reports have investigated the role of posttranscriptional RNA regulation in CTC clusters. Here, we compared alternative splicing (AS) and alternative polyadenylation (APA) profiles between single CTCs and CTC clusters. 994 and 836 AS events were identified in single CTCs and CTC clusters, separately. About ~20% of AS events exhibited alterations between both cell types. The differential splicing of SRSF6 was a core event that caused AS profiles’ disturbance and made CTC clusters more dangerous. Concerning APA, we identified global 3’ UTRs lengthening in CTC clusters compared with single CTCs. This change was mainly regulated by 14 core APA factors, especially PPP1CA. The altered APA profiles boosted the cell cycle of CTC clusters and reflected that CTC clusters endured less oxidative stress. Our study investigated the posttranscriptional regulation mechanisms in CTC clusters, found that the perturbation of AS and APA contributed to the superiority of CTC clusters compared with single CTCs, and laid the foundation for developing antisense oligonucleotides that inhibit metastasis by reducing CTC clusters.